10/7/22 – Weekly Covid-19 Update
CHAP’s COVID-19 Weekly Update
In this “one-stop-shop” update, CHAP will provide a roundup of important COVID-19 information from various federal sources.
All health care providers should be monitoring COVID-19 incidence rates in their state/county on an ongoing basis. The Centers for Disease Control and Prevention CDC provides weekly data about case rates, deaths, testing, and vaccine administration on their COVID tracker webpage.
COVID-19 Variants by region
COVID-19 Variants by region – BA.5 now causes almost 90% of US COVID-19 cases. Estimates of Weighted Proportions of Variants by State/Jurisdiction
Locate county specific vaccination rates at COVID-19 Integrated County View
Variant Types – Map Key
CDC and other Federal COVID-19 Updates:
FDA Update (9/30/22)
The FDA announced updates to its COVID-19 test policy to address public health testing needs during this phase of the COVID-19 public health emergency. Over the last two years more than 400 COVID-19 tests have been granted emergency use authorization and there are generally enough at-home tests, tests that can be used at the point-of-care such as health clinics, and laboratory-based tests to meet testing needs. The FDA is revising its COVID-19 test policy to encourage most COVID-19 test developers to pursue a traditional premarket review pathway for their tests, rather than emergency use authorization. The FDA intends to prioritize its review of emergency use authorization requests on COVID-19 diagnostic tests that are likely to have a significant public health benefit or are likely to fulfill an unmet need. This could include novel technologies like the use of breath samples, or unique features like the ability of a test to detect a new SARS-CoV-2 virus variant. The FDA actions include:
- Reissuing the Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised).
- Updating the FAQs on Testing for SARS-CoV-2.